BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36593359)

  • 1. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
    Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
    Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
    Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
    J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer.
    Wan L; Lin KT; Rahman MA; Ishigami Y; Wang Z; Jensen MA; Wilkinson JE; Park Y; Tuveson DA; Krainer AR
    Cancer Discov; 2023 Jul; 13(7):1678-1695. PubMed ID: 37098965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
    Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
    J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine and arginine rich splicing factor 1 deficiency alters pathways involved in IL-17A expression and is implicated in human psoriasis.
    Su S; Katopodi XL; Pita-Juarez YH; Maverakis E; Vlachos IS; Adamopoulos IE
    Clin Immunol; 2022 Jul; 240():109041. PubMed ID: 35613697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
    Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
    Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
    Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
    Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
    Aktas Samur A; Fulciniti M; Avet-Loiseau H; Lopez MA; Derebail S; Corre J; Minvielle S; Magrangeas F; Moreau P; Anderson KC; Parmigiani G; Samur MK; Munshi NC
    Blood Cancer J; 2022 Dec; 12(12):171. PubMed ID: 36535935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death.
    Arif W; Mathur B; Saikali MF; Chembazhi UV; Toohill K; Song YJ; Hao Q; Karimi S; Blue SM; Yee BA; Van Nostrand EL; Bangru S; Guzman G; Yeo GW; Prasanth KV; Anakk S; Cummins CL; Kalsotra A
    Nat Commun; 2023 Feb; 14(1):551. PubMed ID: 36759613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing factor arginine/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication.
    Zhang Y; Yu X; Sun R; Min J; Tang X; Lin Z; Xie S; Li X; Lu S; Tian Z; Gu C; Teng L; Yang Y
    Clin Transl Med; 2022 Feb; 12(2):e684. PubMed ID: 35184390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics and functional roles of splicing factor autoregulation.
    Ding F; Su CJ; Edmonds KK; Liang G; Elowitz MB
    Cell Rep; 2022 Jun; 39(12):110985. PubMed ID: 35732114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis.
    Li WJ; Huang Y; Lin YA; Zhang BD; Li MY; Zou YQ; Hu GS; He YH; Yang JJ; Xie BL; Huang HH; Deng X; Liu W
    Cell Rep; 2023 Nov; 42(11):113385. PubMed ID: 37938975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRSF1-mediated alternative splicing is required for spermatogenesis.
    Lei WL; Li YY; Du Z; Su R; Meng TG; Ning Y; Hou G; Schatten H; Wang ZB; Han Z; Sun F; Qian WP; Liu C; Sun QY
    Int J Biol Sci; 2023; 19(15):4883-4897. PubMed ID: 37781512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14.
    Feng JF; Yang WY; Wang YD; Xie G; Xu B; Dai CM; Zhang B; Li XH; Wang J; Yang YW
    Oxid Med Cell Longev; 2022; 2022():8645830. PubMed ID: 36062189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
    Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
    Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1.
    Aznarez I; Nomakuchi TT; Tetenbaum-Novatt J; Rahman MA; Fregoso O; Rees H; Krainer AR
    Cell Rep; 2018 May; 23(7):2186-2198. PubMed ID: 29768215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
    Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
    PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The splicing factor SRSF1 stabilizes the mRNA of TSLP to enhance acute lung injury.
    Fu C; Hu Y; Liu J; Yang Y
    Cell Immunol; 2021 Apr; 362():104299. PubMed ID: 33607522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.